Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;57(12):647-53.
doi: 10.1007/s11748-009-0486-1.

Symptomatic gastroesophageal reflux disease after lung transplantation

Ezequiel J Molina  1 , Scott Short, Glen Monteiro, John P Gaughan, Mahender Macha
Affiliations

Symptomatic gastroesophageal reflux disease after lung transplantation

Ezequiel J Molina et al. Gen Thorac Cardiovasc Surg. 2009 Dec.

Abstract

Purpose: Gastroesophageal reflux disease (GERD) is associated with allograft dysfunction after lung transplantation (LTX). We attempted to identify outcomes in LTX recipients with clinical evidence of GERD.

Methods: Retrospective review of 162 LTX recipients at our institution between January 1994 and June 2006 was performed. GERD was confirmed in symptomatic patients by esophagogastroduodenoscopy (EGD) and/or esophagography. Occurrence of biopsy-proven obliterative bronchiolitis (OB) and bronchiolitis obliterans syndrome (BOS) were analyzed. Kaplan-Meier analysis of survival and Cox proportional hazard analysis of risk factors were performed.

Results: GERD was diagnosed in 21 (13%) of patients, usually following LTX (71%). There was no difference in mean survival (1603 +/- 300 vs. 1422 +/- 131 days; log rank P > 0.05), or development of OB (5% vs. 6%, respectively; P > 0.05) in patients with GERD compared with patients without GERD. However, there was correlation between GERD and BOS (P = 0.01).

Conclusions: Symptomatic GERD is increased following LTX. Patients with symptomatic GERD demonstrated an increased incidence of BOS, but survival was not affected in this study. More sensitive and specific diagnostic tools should be implemented in all LTX recipients to investigate the impact of symptomatic and silent GERD and thus improve outcomes after LTX.

PubMed Disclaimer

References

    1. Proc Am Thorac Soc. 2006 Jul;3(5):444-9 - PubMed
    1. Ann Thorac Surg. 2005 Oct;80(4):1254-60 - PubMed
    1. Am J Transplant. 2006 Aug;6(8):1930-8 - PubMed
    1. Clin Transplant. 2003 Aug;17(4):363-8 - PubMed
    1. J Heart Lung Transplant. 2007 Aug;26(8):782-95 - PubMed

MeSH terms

LinkOut - more resources